424-89671-29177
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 537 / WI
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-19
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Loss of apetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-26
-
2021-04-02
Survey response — day 14, dose 1MedDRA: COVID-19, Exposure to SARS-CoV-2 — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Various COVID-19 symptoms from active infection. My case has been mild. I was likely exposed within 1-2 days of receiving the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-16
- 2021-04-30
- 2021-06-18
- 2021-09-17
-
2021-10-29
Dose 2 — Pfizer-BioNTech
-
2021-10-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
-
2021-11-19
Survey response — day 21, dose 2MedDRA: Premature delivery, Premature labour — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Preterm labor and delivery at 34 weeks 5 daysMedDRA releases: 2024-11 · check-in free text available
-
2021-11-19
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2021-11-22
-
2021-11-22
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-19 | Successful 2021-11-22 |
Participant prefers to complete VAERS report online |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Loss of apetite
Release 6 — day 14, dose 1
Symptoms: Various COVID-19 symptoms from active infection. My case has been mild. I was likely exposed within 1-2 days of receiving the vaccine.
Release 10 — day 21, dose 2
Symptoms: Preterm labor and delivery at 34 weeks 5 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Premature delivery | · | · | ✓ |
| SD | Premature labour | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release